Restricted accessOtherFirst published online 2018-12
Recommendations for the Early Management of Acute Ischemic Stroke: A Consensus Statement for Healthcare Professionals from the Indian Stroke Association
BanerjeeTKDasSK.Epidemiology of stroke in India. Neurolxs Asia. 2006; 11; 1–4.
2.
PandianJDSudhanP.Stroke epidemiology and stroke care services in India. J Stroke. 2013; 15(3); 128–134.
3.
Government of India. Burden of Disease in India. New Delhi: Ministry of Health and Family Welfare, Government of India; 2005. Background papers for the National Commission on Macroeconomics.
4.
UeshimaHSekikawaAMiuraKTurinTCTakashimaNKitaY.Cardiovascular disease and risk factors in Asia: a selected review. Circulation. December 16, 2008; 118(25);2702–2709.
5.
KurtzkeJF.Epidemiology of cerebrovascular disease. In: SiekertRG ed. Cerebrovascular Survey: Report of the Joint Council of the Subcommittee on Cerebrovascular Disease, National Institute of Neurological and Communicable Disorders and Stroke, and the National Heart and Lung Institute. Rochester, MN: Whiting Press; 1980; 135-176.
ValappilAVChaudharyNVPraveenkumarRGopalakrishnanBGirijaAS.Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Ann Indian Acad Neurol. 2012;15(1); 19–22.
8.
CDC,NCHS. Underlying Cause of Death 1999-2013 [CDC WONDER Online]. Atlanta, GA: CDS; 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available at: https://wonder.cdc.gov/ucd-icd10.html. Accessed February 3, 2015.
9.
RogerVLGoASLloyd-JonesDM; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011;123(4); e18–209.
10.
SolbergLI.The KISS principle in family practice: keep it simple and systematic. Fam Pract Manag. 2003; 10(7); 63–6.
11.
JauchECCucchiaraBAdeoyeOPart 11: adult stroke: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care [published correction appears in Circulation. 2011;124(15):e404]. Circulation. 2010; 122(3):S818–S828.
12.
JauchECAdamsHP JrAmerican Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.2013; 44(3); 870–947.
13.
PowersWJDerdeynCPBillerJAmerican Heart Association Stroke Council. Focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2015; 46(10); 3020–3035.
14.
Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke4th ed. London: Intercollegiate Stroke Working Party, Royal College of Physicians; 2012.
15.
PrasadKKaulSPadmaMVGorthiSPKhuranaDBakshiA. Stroke management. Ann Indian Acad Neurol. 2011;14(1): S82–S96.
16.
SaccoRLKasnerSEBroderickJP; American Heart Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7); 2064–2089.
17.
EastonJDSaverJLAlbersGW; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40(6):2276.
18.
AlbersGWCaplanLREastonJD; TIA Working Group. Transient ischemic attack—proposal for a new definition. N Engl J Med. 2002;347(21); 1713–6.
19.
MozaffarianDBenjaminEJGoAS; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015; 131(4); e29–322.
20.
DalalPMMalikSBhattacharjeeMPopulation-based stroke survey in Mumbai, India: incidence and 28-day case fatality. Neuroepidemiology. 2008; 31(4); 254–261.
21.
SridharanSEUnnikrishnanJPSukumaranSIncidence, types, risk factors, and outcome of stroke in a developing country: the Trivandrum Stroke Registry. Stroke. 2009; 40(4)>; 1212–1218.
22.
WasayMKhatriIAKaulS.Stroke in South Asian countries. Nat Rev Neurol. 2014; 10(3); 135–143.
23.
MullerRPfefferkornTVatankhahBAdmission facility is associated with outcome of basilar artery occlusion. Stroke. 2007; 38(4); 1380–1383.
24.
Perez de La OssaNSanchez-OjangurenJInfluence of the stroke code activation source on the outcome of acute ischemic stroke patients. Neurology. 2008; 70(15);1238–1243.
25.
SilvestrelliGParnettiLPaciaroniMEarly admission to stroke unit influences clinical outcome. Eur J Neurol. 2006; 13(3); 250–255.
26.
Health Quality Ontario. Effectiveness of Stroke Unit Care: A Special Report [Internet]. Toronto: Queen’ Printer for Ontario; 2014 October: 42 pp.
27.
National Stroke Foundation. Acute Stroke Services Framework 2008: A Framework to Enable the Delivering and Monitoring of Optimal Acute Stroke Care Across Australia. Melbourne: National Stroke Foundation; 2008.
28.
Durai PandianJPadmaVVijayaPSylajaPNMurthyJM.Stroke and thrombolysis in developing countries. Int J Stroke. 2007;2(1); 17–26.
29.
AshrafVVManeeshMPraveenkumarRSaifudheenKGirijaAS.Factors delaying hospital arrival of patients with acute stroke. Ann Indian Acad Neurol [serial online]. 2015[cited 2016 Mar 11]; 18(2); 162–166.
30.
Govt. of Odisha. 108 Services, National Ambulance Service: A joint initiative of MoHFW, GoI and Govt. of Odisha. Bhubaneshwar, Odisha: Government of Odisha.
31.
FonarowGCSmithEESaverJL. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation.; 2011; 123(7); 750–758.
32.
Srivastava MV.Padma. Management of stroke: he triumphs and the travails. Neurol India. 2016; 64(1) ; 6–7.
33.
PandeyS.Challenges in neurological practice in developing countries. Indian J Public Health. 2012; 56(3); 227–230
34.
DerexLAdelinePNighoghossianNHonnoratJTrouillasP.Factors influencing early admission in a French stroke unit. Stroke. 2002; 33(1); 153–159.
35.
FerroJMMeloTPOliveiraVCrespoMCanhaoPPintoAN.An analysis of admission delay of acute strokes. Cerebrovasc Dis. 1994; 4; 72–5.
36.
HarrafFSharmaAKBrownMMLeesKRVassRIKalraL.A multicentre observational study of presentation and early assessment of acute stroke. BMJ. 2002; 325(7354): 17.
37.
MorrisDLRosamondWMaddenKSchultzCHamiltonS.Prehospital and emergency department delays after acute stroke: The Genentech stroke presentation survey. Stroke. 2000; 31(11);2585–2590.
38.
EvensonKRForakerREMorrisDLRosamondWD.A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009; 4(3); 187–199.
39.
JinHZhuSWeiWJ; for China QUEST (Quality Evaluation of Stroke Care and Treatment) Investigators. Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke. 2012; 43(2); 362–370.
40.
JorgensenHSNakayamaHReithJRaaschouHOOlsenTS.Factors delaying hospital admission in acute stroke: the Copenhagen stroke study. Neurology. 1996; 47(2);383–387.
41.
KothariRJauchEBroderickJAcute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 1999; 33(1); 3–8.
42.
CarrollCHobartJFoxCTeareLGibsonJ.Stroke in Devon: Knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry. 2004; 75(4); 567–571.
43.
LeiferDBravataDMConnorsJJ; American Heart Association Special Writing Group of the Stroke Council; Atherosclerotic Peripheral Vascular Disease Working Group ; Council on Cardiovascular Surgery and Anesthesia Council on Cardiovascular Nursing. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations—a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(3); 849–877.
44.
SunCHRiboMGoyalMDoor-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc. 2014; 3(2): e000859.
45.
RaiATSmithMSBooSTarabishyARHobbsGRCarpenterJS.The ‘ pit-crew’ model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project. J Neurointerv Surg. 2016; 8(5); 447–452.
46.
MehtaBPLeslie-mazwiTMChandraRVReducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc. 2014; 3(6): e000963.
47.
PerfectServe.Rapid team notification accelerates acute stroke treatment at St. John Hospital and Medical Center. 2015. Available at: http://www.perfectserve.com/wp-content/uploads/2016/01/St-John-Providence-Stoke-Success-Story.pdf. Accessed June 15, 2018.
48.
SrivastavaPVSudhanPKhuranaD etc.Telestroke a viable option to improve stroke care in India. Int J Stroke. 2014; 9(A100); 133–134.
49.
Neurosciences health network. Model of Stroke Care 2012. Perth, WA: Department of Health, State of Western Australia; 2012.
50.
SharmaMSethiNK.Meeting the challenges of stroke in India. Neurology. 2014; 82; 195–196.
51.
WallHKBeaganBMO’NeillJFoellKMBoddie-WillisCL.Addressing stroke signs and symptoms through public education: the Stroke Heroes Act FAST campaign. Prev Chronic Dis. 2008; 5(2): A49.
52.
JurkowskiJMManicciaDMDennisonBASamuelsSJSpicerDA.Awareness of necessity to call 9-1-1 for stroke symptoms, upstate New York. Prev Chronic Dis. 2008; 5(2): A41.
53.
HarbisonJHossainOJenkinson DDavisJLouwSJFordGA.Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003; 34(1); 71–76.
54.
ChenSSunHLeiYValidation of the Los Angeles pre-hospital stroke screen (LAPSS) in a Chinese urban emergency medical service population. PLoS One. 2013; 8(8): e70742xs.
55.
KidwellCSStarkmanSEcksteinMWeemsKSaverJL.Identifying stroke in the field: prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke. 2000; 31(1); 71–76.
56.
FothergillRTWilliamsJEdwardsMJRussellITGompertzP.Does use of the recognition of stroke in the emergency room stroke assessment tool enhance stroke recognition by ambulance clinicians? Stroke. 2013;44(11); 3007–3012.
57.
PurruckerJCHametnerCEngelbrechtABrucknerTPoppEPoliS.Comparison of stroke recognition and stroke severity scores for stroke detection in a single cohort. J Neurol Neurosurg Psychiatry. 2015; 86(9); 1021–1028.
58.
MingfengHZhixinWQihongGLiandaLYanbinYJinfangF.Validation of the use of the ROSIER scale in prehospital assessment of stroke. Ann Indian Acad Neurol. 2012 ; 15(3); 191–195.
59.
NorAMMcAllisterCLouwSJAgreement between ambulance paramedic- and physician-recorded neurological signs with face arm speech test (FAST) in acute stroke patients. Stroke. 2004; 35(6); 1355–1359.
60.
McHughMTanabePMcClellandMKhareRK.More patients are triaged using the emergency severity index than any other triage acuity system in the United States. Acad Emerg Med2012; 19(1); 106–109.
61.
RamanujamPCastilloEPatelEVilkeGWilsonMPDunfordJV.Prehospital transport time intervals for acute stroke patients. J Emerg Med. 2009; 37(1); 40–45.
62.
KerrGRayGWuOStottDJLanghorneP.Elevated troponin after stroke: a systematic review. Cerebrovasc Dis. 2009; 28(3); 220–226.
63.
JamesPEllisCJWhitlockRMMcNeilARHenleyJAndersonNE.Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ. 2000; 320(7248);1502–1504.
64.
Di AngelantonioEFiorelliMToniDPrognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatr. 2005; 76(1); 76–81.
65.
JensenJKKristensenSRBakSAtarDHøilund-CarlsenPFMickleyH.Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol. 2007; 99(1); 108–112.
66.
AyHKoroshetzWJBennerTNeuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006; 66(9); 1325–1329.
67.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24); 1581–1587.
68.
LydenPRamanRLiuLEmrMWarrenMMarlerJ.National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke. 2009; 40(7); 2507–2511.
69.
BushnellCDJohnstonDCCGoldsteinLB.Retrospective assessment of initial stroke severity: comparison of the NIH stroke scale and the Canadian neurological scale. Stroke. 2001; 32(3); 656–660.
70.
TongEHouQFiebachJBWintermarkM.The role of imaging in acute ischemic stroke. Neurosurg Focus. 2014; 36(1):e3.
71.
NaDGSohnC-HKimEY.Imaging-based management of acute ischemic stroke patients: current neuroradiological perspectives. Korean J Radiol. 2015; 16(2); 372–390.
72.
BarberPADemchukAMZhangJBuchanAM.Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000; 355(9216); 1670–1674.
73.
WahlgrenNAhmedNErikssonN; safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITSMOST). Stroke. 2008; 39(12); 3316–3322.
74.
BalamiJSHadleyGSutherlandBAKarbalaiHBuchanAM.The exact science of stroke thrombolysis and the quiet art of patient selection. Brain. 2013; 136(12); 3528–3553.
75.
VymazalJRuleshAMKellerJJanouskovaL.Comparison of CT and MR imaging in ischemic stroke. Insights Imaging. December, 2012; 3(6)619–627.
76.
SaverJL.Time Is Brain—Quantified. Stroke. 2006; 37(1); 263–266.
77.
MeretojaAKeshtkaranMSaverJLStroke thrombolysis: save a minute, save a day. Stroke. 2014; 45(4); 1053–1058.
78.
FransenPSSBerkhemerOALingsmaHF; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators. Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2016; 73(2); 190–196.
79.
HwangY.-H.KangD.-H.KimY.-W.KimY.-S.ParkS.-P.LiebeskindD.S.Impact of time-to-reperfusion on outcome in patients with poor collaterals. Am J Neuroradiol2015; 36(3); 495–500.
80.
GilesMFRothwellPM.Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007; 6(12); 1063–1072
81.
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke: EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993; 342(8882); 1255–1262.
82.
KernanWNHorwitzRIBrassLMViscoliCMTaylorKJ.A prognostic system for transient ischemia or minor stroke. Ann Intern Med. 1991; 114(7); 552–557.
83.
CoullAJLovettJKRothwellPM; Oxford Vascular Study.Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004; 328(7435); 326–328.
84.
HillMDYiannakouliasNJeerakathilTTuJVSvensonLWSchopflocherDP.The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004; 62(11);2015–2020.
85.
EliasziwMKennedyJHillMDBuchanAMBarnettHJ; North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004; 170(7); 1105–1109.
86.
GladstoneDJKapralMKFangJLaupacisATuJV.Management and outcomes of transient ischemic attacks in Ontario. CMAJ. 2004; 170(7); 1099–1104
87.
JohnstonSCRothwellPMNguyen-HuynhMNValidation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet. 2007; 369(9558); 283–292.
88.
AndersonDCBottiniAGJagiellaWMA pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke. 1991; 22(9); 1137–1142.
89.
NighoghossianNTrouillasPAdeleinePSalordF.Hyperbaric oxygen in the treatment of acute ischemic stroke: a double-blind pilot study. Stroke. 1995; 26(8); 1369–1372.
DeABalaNN.Drug treatment for hypertensive emergencies. Int J Res Pharm Biomed Sci. 2011; 2(2); 2229–3701.
92.
HuangYSharmaVKRobinsonT; Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Int J Stroke. 2015; 10(5);778–788.
93.
BrunoABillerJAdamsHPAcute blood glucose level and outcome from ischemic stroke: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) InvestigatorsNeurology. 1999; 52(2); 280–284.
94.
McDonnellMEUmpierrezGE.Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am. 2012; 41(1); 175–201.
95.
HajatCHajatSSharmaP.Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000; 31(2); 410–414.
96.
GreerDMFunkSEReavenNLOuzounelliMUmanGC.Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke. 2008; 39(11); 3029–3035.
97.
ChristensenHFogh ChristensenABoysenG.Abnormalities on ECG and telemetry predict stroke outcome at 3 months. J Neurol Sci. 2005; 234(1-2); 99–103.
98.
CavalliniAMicieliGMarcheselliSQuagliniS.Role of monitoring in management of acute ischemic stroke patients. Stroke. 2003; 34(11); 2599–2603.
99.
PongmoragotJRabinsteinAANilanontYSwartzRHZhouLSaposnikG.Pulmonary Embolism in Ischemic Stroke: Clinical Presentation, Risk Factors, and Outcome. J Am Heart Assoc. 2013; 2: 372.
100.
HackeWKasteMFieschiCIntravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274(13); 1017–1025.
101.
HackeWKasteMFieschiCRandomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998; 352(9136); 1245–1251.
102.
ClarkWMAlbersGWMaddenKPHamiltonS.Thromblytic therapy in acute ischemic stroke study investigators. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke. 2000; 31(4); 811–16.
103.
ClarkWMWissmanSAlbersGWJhamandasJHMaddenKPHamiltonS.Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999; 282(21); 2019–2202.
104.
SandercockPWardlawJMLindleyRIThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial [published correction appears in Lancet. 2012;380(9843):730]. Lancet. 2012; 379(9834); 2352–2363.
105.
ChengNTKimAS.Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. DemaerschalkBM ed.Neurohospitalist. 2015; 5(3); 101–109.
106.
IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol. 2013; 12(8); 768–776.
107.
DemaerschalkBMKleindorferDOAdeoyeOM; American Heart Association Stroke Council and Council on Epidemiology and Prevention.Scitific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016; 47(2); 581–641.
108.
WinklerAMTormeyCA.Pathology consultation on monitoring direct thrombin, inhibitors, and overcoming their effects in bleeding patients. Am J Clin Path. 2010; 140(5); 610–622.
109.
BehrouzR. Intravenous tenecteplase in acute ischemic stroke: an updated review. J Neurol. 2014; 261(6); 1069–1072.
110.
MohrJPWolfPAGrottaJCMoskowitzMAMaybergMRvonKummer R ed. Stroke pathophysiology, diagnosis, and management. 5th ed. Philadelphia, PA: Elsevier/Saunders; 2011; 946–948.
111.
ParsonsMSprattNBivardAA randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med.; 2012; 366(12): 1099–1107.
112.
HuangXCheripelliBKLloydSMAlteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol.; 2015; 14(4); 368–376.
113.
HaleyEC JrThompsonJLGrottaJC; Tenecteplase in Stroke Investigators Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke.; 2010; 41(4);707–711.
114.
HuangXMacIsaacRThompsonJL. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta- analysis of randomized controlled trials. Int J Stroke.; 2016; 11(5);534–543.
115.
LogalloNNovotnyVThomassenL. The Norwegian Tenecteplase Stroke Trial (NOR-TEST): randomised controlled trial of Tenecteplase vs. Alteplase in acute ischaemic stroke (abstract). Eur Strk J. 2017; 2(IS); 3–97.
116.
PowersWJRabinsteinAAAckersonT, on behalf of the American Heart Association Stroke Council. AHA/ASA Guidelines: 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018; 49(6).
117.
CTRI/2015/02/005556 (Registered on February 19, 2015)
118.
CTRI/2009/091/000251(Registered on June 24, 2009).
119.
KlicheWKrechIMichelMCSangoleNVSathayeS.Comparison of clot lysis activity and biochemical properties of originator tenecteplase (Metalyse®) with those of an alleged biosimilar. Front Pharmacol. 2014; 5: 7.
120.
RhaJHSaverJL.The impact of recanalization on ischemic stroke outcome: a meta analysis. Stroke. 2007; 38(3); 967–973
121.
BhatiaRHillMDShobhaNLow rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010; 41(10); 2254–2258.
122.
HudedVNairRNde SouzaRDVyasD.Endovascular treatment of acute ischemic stroke: An Indian experience from a tertiary care center. Neurology India. 2014: 62(3); 276–279.
123.
BalasubramanianAMitchellPDowlingRYanBEvolution of endovascular therapy in acute stroke: implications of device development. J Stroke. May, 2015; 17(2); 127–137.
124.
BadhiwalaJHNassiriFAlhazzaniWEndovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. November 3, 2015; 314(17); 1832–1843.
125.
FugateJEKlunderAMKallmesDF. What is meant by “TICI”? Am J Neuroradiol. 2013; 10:3496
126.
IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004; 35(4); 904–911.
127.
IMS Trial Investigators.The Interventional Management of Stroke (IMS) II Study. Stroke. 2007; 38(7); 2127#x2013;2135.
128.
ErnstRPancioliATomsickTCombined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke. 2000; 31(11); 2552#x2013;2557.
129.
KhatriPAbruzzoTYeattsSDNicholsCBroderickJPTomsickTA;IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009; 73(13); 1066#x2013;1072.
130.
ChamorroA.Heparin in acute ischemic stroke: the case for a new clinical trial. Cerebrovasc Dis. 1999; 9(3); 16#x2013;23.
131.
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998; 279(16); 1265–1272.
132.
SaxenaRLewisSBergeESandercockPAKoudstaalPJ.Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001; 32(10); 2333–2337.
133.
ChamorroABusseOObachV; RAPID Investigators. The rapid anticoagulation prevents ischemic damage study in acute stroke: final results from the writing committee. Cerebrovasc Dis. 2005; 19(6); 402#x2013;404.
134.
KakkosSKKirkilesisGITsolakisIAEditor;s choice— efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg.; 2014; 48(5); 565#x2013;575.
135.
SuriMFHusseinHMAbdelmoulaMMDivaniAAQureshiAI. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience. Med Sci Monit. 2008; 14(10): I39#x2013;I44.
136.
MeyerDMAlbrightKCAllisonTAGrottaJC.LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2008; 17(1); 26#x2013;29.
137.
DenglerRDienerHCSchwartzA; Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010; 9(2);159#x2013;166.
138.
KennedyJHillMDRyckborstKJEliasziwMDemchukAMBuchanAMFASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007; 6(11); 961#x2013;969.
139.
AdamsRJAlbersGAlbertsMJUpdate to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [published correction appears in Stroke. 2010;41:e455]. Stroke. 2008; 39(5); 1647#x2013;1652.
140.
SaccoRLAdamsRAlbersGGuidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006; 37(2);577#x2013;617.
141.
LapchakPAAraujoDM.Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. Am J Cardiovasc Drugs. 2003; 3(2); 87#x2013;94.
142.
SeitzRJSieblerM.Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease. Curr Vasc Pharmacol. 2008; 6(1); 29#x2013;36.
143.
The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke. 2000; 31(3); 601#x2013;609.
144.
AdamsHP JrEffronMBTornerJEmergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke. 2008; 39(1); 87#x2013;99.
145.
BukowSCDaffertshoferMHennericiMG.Tirofiban for the treatment of ischaemic stroke. Expert Opin Pharmacother. 2006; 7(1); 73#x2013;79.
146.
Del PaceSScheggiV.Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0. Intern Emerg Med. 2006; 1(3); 250#x2013;252.
147.
MangiaficoSCelleriniMNenciniPGensiniGInzitariD.Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. Am J Neuroradiol. 2005; 26(10); 2595#x2013;2601.
148.
MangiaficoSCelleriniMNenciniPGensiniGInzitariD.Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases. Stroke. 2005; 36(10); 2154#x2013;2158.
149.
SeitzRJMeiselSMollMWittsackHJJunghansUSieblerM.The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology. 2004; 62(11); 2110#x2013;2112.
150.
SongTJLeeKOKimDJLeeKY.Rescue treatment with intra-arterial tirofiban infusion and emergent carotid stenting. Yonsei Med J. 2008; 49(5); 857#x2013;859.
151.
North American Symptomatic Carotid Endarterectomy Trial Collaborators; BarnettHJMTaylorDWHaynesRBBeneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325(7); 445#x2013;453.
152.
SbarigiaEToniDSpezialeFAcconciaMCFioraniP.Early carotid endarterectomy after ischemic stroke: the results of a prospective multicenter Italian study. Eur J Vasc Endovasc Surg. 2006; 32(3); 229#x2013;235.
153.
BallottaEMeneghettiGDa GiauGManaraRSaladiniMBaracchiniC.Carotid endarterectomy within 2 weeks of minor ischemic stroke: a prospective study. J Vasc Surg. 2008; 48(3); 595#x2013;600.
154.
HuberRMüllerBTSeitzRJSieblerMMödderUSandmannW.Carotid surgery in acute symptomatic patients. Eur J Vasc Endovasc Surg. 2003; 25(1); 60#x2013;67.
155.
WelshSMeadGChantHPictonAO’NeillPAMcCollumCN.Early carotid surgery in acute stroke: a multicentre randomised pilot study. Cerebrovasc Dis. 2004; 18(3); 200#x2013;205.
RerkasemKRothwellPM.Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke. 2009; 40(10); 564#x2013;572.
YamamotoHBogousslavskyJvan MelleG.Different predictors of neurological worsening in different causes of stroke. Arch Neurol. 1998; 55; 481#x2013;486.
160.
MannoEMNicholsDAFulghamJRWijdicksEF.Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc. 2003; 78(2); 156#x2013;160.
161.
RopperAHShafranB.Brain edema after stroke: clinical syndrome and intracranial pressure. Arch Neurol. 1984; 41(1); 26#x2013;29.
162.
HeoJHHanSWLeeSK.Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med. 2005; 39(1); 51#x2013;70.
KoenigMABryanMLewinJLMirskiMAGeocadinRGStevensRD.Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13);1023#x2013;1029.
165.
VahediKHofmeijerJJuettlerE; DECIMAL, DESTINY, HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007; 6(3); 215#x2013;222.
166.
FoerchCLangJMKrauseJFunctional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004; 101(2); 248#x2013;254.
167.
CurryWT JrSethiMKOgilvyCSCarterBS.Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery. 2005; 56(4); 681#x2013;692.
168.
CarterBSOgilvyCSCandiaGJRosasHDBuonannoF.One-year outcome after decompressive surgery for massive non dominant hemispheric infarction. Neurosurgery. 1997; 40(6); 1168#x2013;1175
169.
MottoCCicconeAAritzuEHemorrhage after an acute ischemic stroke. MAST-I Collaborative Group. Stroke. 1999; 30(4); 761–764.
170.
DerexLHermierMAdeleinePClinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatr. 2005; 76(1); 70#x2013;75.
171.
The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997; 28(11); 2109#x2013;2118.
172.
KimJ-THeoS-HParkM-SChangJChoiK-HChoK-H.Use of antithrombotic after hemorrhagic transformation in acute ischemic stroke. PLoS ONE. 2014; 9(2): 89798.
173.
FrenchKFWhiteJHoeschRE.Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator. Neurocrit Care. 2012; 17(1); 107#x2013;111.
174.
BayramogluMKaratasMLeblebiciBCetinNSözaySTurhanN.Hemorrhagic transformation in stroke patients. Am J Phys Med Rehabil. 2003; 82(1); 48#x2013;52.
175.
KohMGPhanTGAtkinsonJLWijdicksEF.Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect. Stroke. 2000; 31(9); 2062#x2013;2067.
176.
KilincerCAsilTUtkuUFactors affecting the outcome of decompressive craniectomy for large hemispheric infarctions: a prospective cohort study. Acta Neurochir (Wien). 2005; 147(6);587#x2013;594.
177.
AlbertiAPaciaroniMCasoVVentiMPalmeriniFAgnelliG.Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag. 2008; 4(3);715#x2013;720.
VeerbeekJMvanWegen EvanPeppen R. What is the evidence for physical therapy poststroke? A systematic review and meta-analysis. PLoS One.2014; 9(2)e87987.
180.
VanPeppen RPKwakkelGWood-DauphineeSHendriksHJVan derWees PJDekkerJThe impact of physical therapy on functional outcomes after stroke: what’s the evidence? Clin Rehabil.; 2004; 18(8); 833#x2013;862.
181.
DalalPM.Studies in young and elderly: risk factors and strategies for stroke prevention. J Assoc Physicians India. 1997; 45 ;125#x2013;131.
182.
BanerjeeTKMukherjeeCSSarkhelA.Stroke in the urban population of Calcutta- an epidemiological study. Neuroepidemiology. 2001; 20(3); 201#x2013;207.
183.
BhattacharyaSSahaSPBasuADasSK.A 5-year prospective study of incidence, morbidity and mortality profile of stroke in a rural community of Eastern India. J Indian Med Assoc. 2005; 103(12); 655#x2013;659.
184.
American Heart Association. Understanding Stroke Risk. Dallas, TX: American Heart Association; 2016
185.
National Stroke Foundation. Make Yourself Strokesafe: Understand and Prevent Stroke (brochure). Melbourne: National Stroke Foundation; 2009.
186.
HankeyG.Ischaemic stroke— prevention is better than cure. J Royal Coll Phys Edinb. 2010; 40(1); 56#x2013;63.
187.
KiefeCIAllisonJJWilliamsODPersonSDWeaverMTWeissmanNW.Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA. 2001; 285(22); 2871#x2013;2879.
188.
HincheyJAShephardTTonnSTRuthazerRSelkerHPKentDM.Benchmarks and determinants of adherence to stroke performance measures. Stroke. 2008; 39(5); 1619#x2013;1620.
189.
LindsayP1FurieKLDavisSMDonnanGANorrvingB.World Stroke Organization global stroke services guidelines and action plan. Int J Stroke. 2014;9 Suppl A100:4#x2013;13.
190.
KumarSKMurthyGVSKinraSGoenkaSKuperH.Evaluation of the feasibility and acceptability of the ‘Care for Stroke’ intervention in India, a smartphone-enabled, carer-supported, educational intervention for management of disability following stroke. BMJ. 2016; 6(2):9243.
191.
SinghalABSylajaPNKhuranaDQuality of Stroke Care in India: the Indo-US Stroke Project. Stroke. 2015; 46: ATMP84.
192.
MediCHankeyGJFreedmanSB.Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke2010; 41(11); 2705#x2013;2713.
